SCEs occur more frequently in World Health Organization grade 2 and 3 astrocytoma and oligodendroglial tumors and gliomas with an isocitrate dehydrogenase (IDH) mutation. The gene discussed is IDH3A; the disease is astrocytoma (excluding glioblastoma).